Abstract
AbstractThe Hepatitis C virus (HCV) envelope glycoprotein E1 forms a noncovalent heterodimer with E2, the main target of neutralizing antibodies. How E1-E2 interactions influence viral fitness and contribute to resistance to E2-specific antibodies remains largely unknown. We investigate this problem using a combination of fitness landscape and evolutionary modelling. Our analysis indicates that E1 and E2 proteins collectively mediate viral fitness, and suggests that fitness-compensating E1 mutations may accelerate escape from E2-targeting antibodies. Our analysis also identifies a set of E2-specific human monoclonal antibodies that are predicted to be especially resilient to escape via genetic variation in both E1 and E2, providing directions for robust HCV vaccine development.
Publisher
Cold Spring Harbor Laboratory
Reference111 articles.
1. World Health Organization, “Hepatitis C, Fact sheet,” 2022. https://www.who.int/news-room/fact-sheets/detail/hepatitis-c
2. Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the united states;Infectious Agents and Cancer,2016
3. Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort;Hepatology,2018
4. Understanding hepatitis C virus drug resistance: Clinical implications for current and future regimens;Topics in Antiviral Medicine,2017
5. Formation of native hepatitis C virus glycoprotein complexes
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献